Vident Advisory’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,039
Closed -$205K 1316
2023
Q3
$205K Buy
+8,039
New +$205K 0.01% 1102